The levels of CHI3L1 in the cerebrospinal fluid (CSF) and plasma of AD patients were significantly higher than those in healthy controls, and its concentration increased as the disease progressed (Batinic et al., 2012; Muszynski et al., 2017; Hampel et al., 2018). Here, CHI3L1 is linked to Alzheimer disease.